Bacterin International Holdings Inc Stock NYSE
Stocks
BONE
US05644R1014
Medical Equipment, Supplies & Distribution
|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| Market Cap | 44.89M 39.14M 36.86M 33.57M 62.95M 4.3B 63.02M 441M 170M 2.19B 169M 165M 7.07B | P/E 2026 * |
-2.82x | P/E 2027 * | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 44.89M 39.14M 36.86M 33.57M 62.95M 4.3B 63.02M 441M 170M 2.19B 169M 165M 7.07B | EV / Sales 2026 * |
0.45x | EV / Sales 2027 * | 0.41x |
| Free-Float |
84.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bacterin International Holdings Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Sean Browne
CEO | Chief Executive Officer | 60 | 2019-10-06 |
Scott Neils
DFI | Director of Finance/CFO | 42 | 2022-01-02 |
| Chief Operating Officer | 40 | 2023-01-15 |
| Director | Title | Age | Since |
|---|---|---|---|
John Bakewell
BRD | Director/Board Member | 65 | 2018-01-31 |
Sean Browne
BRD | Director/Board Member | 60 | 2019-10-29 |
| Chairman | 55 | 2022-08-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -2.72% | -27.51% | -3.61% | 106B | |
| +0.63% | +2.53% | -24.58% | -1.66% | 11.56B | |
| -1.39% | -5.59% | +90.89% | +114.66% | 9.66B | |
| +4.88% | +7.05% | -49.75% | -67.60% | 4.02B | |
| +2.01% | +2.38% | -26.40% | +18.98% | 2.34B | |
| -1.38% | +1.88% | -3.58% | -60.40% | 2.22B | |
| +1.06% | +5.94% | - | - | 1.93B | |
| +1.56% | +3.54% | -18.85% | -27.68% | 1.53B | |
| Average | +0.83% | +2.82% | -8.54% | -3.90% | 17.35B | |
| Weighted average by Cap. | -0.15% | +0.31% | -19.05% | +2.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 99.44M 86.7M 81.66M 74.37M 139M 9.53B 140M 978M 377M 4.85B 374M 365M 15.66B | 110M 96.11M 90.52M 82.44M 155M 10.56B 155M 1.08B 418M 5.38B 414M 405M 17.36B |
| Net income | -16.11M -14.05M -13.23M -12.05M -22.59M -1.54B -22.62M -158M -61.07M -786M -60.52M -59.18M -2.54B | -4.25M -3.7M -3.49M -3.18M -5.96M -407M -5.96M -41.77M -16.1M -207M -15.96M -15.6M -669M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- XTNT Stock
- BONE Stock
Select your edition
All financial news and data tailored to specific country editions
